ProShare Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

ProShare Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42K	Sell	10,040 -2,439	-20%	-$11.7K	﹤0.01%	1801
2025 Q4	$60K	Buy	12,479 +1,368	+12%	+$6.62K	﹤0.01%	1934
2025 Q3	$56.2K	Sell	11,111 -2,039	-16%	-$9.01K	﹤0.01%	1923
2025 Q2	$53K	Buy	13,150 +432	+3%	+$1.41K	﹤0.01%	1985
2025 Q1	$34.7K	Sell	12,718 -3,623	-22%	-$13K	﹤0.01%	1994
2024 Q4	$69.5K	Buy	16,341 +5,377	+49%	+$20.5K	﹤0.01%	2135
2024 Q3	$32.2K	Buy	+10,964	New	+$34.9K	﹤0.01%	2020
2024 Q2	–	Sell	-10,816	Closed	-$30.8K	–	1868
2024 Q1	$30.8K	Buy	+10,816	New	+$33.4K	﹤0.01%	1954

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $221M AUM

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's SRTA Position: Q1 2026 in Review

ProShare Advisors reduced its Strata Critical Medical Inc (SRTA) stake by 20% in Q1 2026, selling an estimated $11.7K and leaving 10,040 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

ProShare Advisors first reported a position in SRTA in Q1 2024 and has held it in 8 quarters since. The position peaked at $69.5K in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

ProShare Advisors held 10,040 shares of Strata Critical Medical Inc worth $42K as of Q1 2026.
ProShare Advisors sold 2,439 Strata Critical Medical Inc shares in Q1 2026, an estimated $11.7K.
Strata Critical Medical Inc made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1801 holding.
ProShare Advisors first reported a position in Strata Critical Medical Inc in Q1 2024 and has held it in 8 quarters since.
ProShare Advisors's Strata Critical Medical Inc position peaked at $69.5K in Q4 2024.
125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.